Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Metabolic Intervention Before Pregnancy in PCOS
NCT03383068Phase 4Unknown
- Sponsor
- Renji Hospital
- Start
- Jan 2018
- Primary completion
- Dec 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acarbose, exenatide, orlistat in polycystic ovary syndrome (PCOS), impaired glucose tolerance (IGT), sponsored by Renji Hospital. Status: unknown.
02
Drugs
acarboseexenatideorlistat
03
Conditions
polycystic ovary syndrome (PCOS)impaired glucose tolerance (IGT)
Beyond the preview
Go deeper on NCT03383068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03383068.